[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.140.188. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Clinical Observation
June 10, 2002

Fever of Unknown Origin Caused by Multiple MyelomaA Report of 9 Cases

Author Affiliations

From the Divisions of General Internal Medicine (Dr Mueller), Infectious Diseases and Internal Medicine (Dr Terrell), and Hematology and Internal Medicine (Dr Gertz), Mayo Clinic, Rochester, Minn.

Arch Intern Med. 2002;162(11):1305-1309. doi:10.1001/archinte.162.11.1305
Abstract

Background  Most authorities regard multiple myeloma as a rare cause of fever and not a cause of fever of unknown origin (FUO).

Objective  To describe a series of patients with FUO caused by multiple myeloma.

Methods  We reviewed the clinical features of 9 patients seen at Mayo Clinic from January 1, 1975, to February 1, 2001, with FUO caused by multiple myeloma.

Results  Fever of unknown origin caused by multiple myeloma was found in 9 patients (6 men and 3 women). All patients satisfied accepted criteria for FUO. The mean ± SD time from the onset of fevers to the initial physician evaluation was 4.8 ± 2.0 weeks. The mean time from the initial physician evaluation to the diagnosis of multiple myeloma was 11.4 ± 6.5 weeks. The mean age at diagnosis of multiple myeloma was 55.9 ± 6.9 years. All 9 patients were anemic. Peripheral blood smears were available for 8 patients, and all had rouleaux formations. All 9 patients underwent exhaustive testing to determine the cause of fevers. Further testing was done in 6 patients subsequent to the diagnosis of multiple myeloma. Acetaminophen or nonsteroidal anti-inflammatory drugs or both relieved fevers in all patients who received them. All 8 patients who received chemotherapy experienced resolution of fevers. The median actuarial survival of the patient cohort was 38 months.

Conclusions  Multiple myeloma can cause FUO. When appropriate, clinicians should include multiple myeloma in the differential diagnosis of FUO to reduce unnecessary testing, rapidly establish the diagnosis, and initiate effective treatments.

×